Skip to main content
. 2020 Dec 9;35(3):661–678. doi: 10.1038/s41375-020-01104-1

Fig. 1. Role of EV repertoire and potential clinical applications in cancer.

Fig. 1

EV cargo includes bioactive molecules on EV surface (adhesion molecules, tetraspanins, molecules involved in antigen presentation, proteoglycans, lipids, P-glycoprotein P-gp and tumor specific antigens) and molecular content (DNA, mRNA, microRNA, long noncoding RNA, short noncoding RNA, circular RNA, metabolites, heat shock proteins, enzymes). EVs and their components play multiple roles in cancer and have peculiar physicochemical characteristics, thus holding a potential clinical utility as biomarkers as well as therapeutic targets and agents.